Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 4/20 | 0.55 |
| ▸ | NPY1R | P25929 | 3/20 | 0.55 |
| ▸ | NPY2R | P49146 | 3/20 | 0.55 |
| ▸ | MME | P08473 | 4/20 | 0.51 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.49 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30183809 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30367620 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30882680 | 1.00 | NPY4R (0.55) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30361704 | 0.99 | NPY4R (0.54) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30183642 | 0.98 | NPY4R (0.58) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30367693 | 0.96 | NPY4R (0.52) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL30368238 | 0.95 | NPY4R (0.53) | NPY4RNPY1RNPY2RMMEERAP2 | |
| SCHEMBL32672641 | 0.95 | MME (0.56) | NPY4RNPY1RNPY2RMME | |
| SCHEMBL32672550 | 0.95 | MME (0.56) | NPY4RNPY1RNPY2RMME | |
| SCHEMBL30368083 | 0.94 | NPY4R (0.66) | NPY4RNPY1RNPY2RERAP2NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115989236-A | Antimicrobial peptidomimetics | 斯派西斯公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115989236-A | Antimicrobial peptidomimetics | 斯派西斯公司 | 2023-04-18 | — | — | CN | disclosed |